Aptevo Therapeutics Inc. — Director's Dealing 2018

Aug 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2018-08-09

Reporting Person: Mitchell Shawnte (SVP, GC and Corporate Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-09	Common Stock	M	1630	—	Acquired	76135	Direct
2018-08-09	Common Stock	F	383	$4.50	Disposed	75752	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-09	Restricted Stock Units	$	M	1630	Disposed		Common Stock (1630)	Direct

Footnotes

F1: Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis.

F2: On August 10, 2015, the reporting person was granted 4,892 restricted stock units. 1,631 shares of common stock underlying the restricted stock units vested on each of August 9, 2016 and August 9, 2017, and 1,630 vested on August 9, 2018.